We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+9.66%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$9.13B
AUM Growth
+$334M
Cap. Flow
-$281M
Cap. Flow %
-3.08%
Top 10 Hldgs %
21.52%
Holding
2,368
New
73
Increased
154
Reduced
1,152
Closed
75

Sector Composition

Rank Sector Weight
1 Technology 22.17%
2 Healthcare 13.84%
3 Financials 12.41%
4 Consumer Discretionary 11.36%
5 Industrials 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WWD icon
601
Woodward
WWD
$21.3B
$2.66M 0.03%
33,217
-445
-1% -$35.8K
JBL icon
602
Jabil
JBL
$38.7B
$2.66M 0.03%
77,588
-3,860
-5% -$129K
EWBC icon
603
East-West Bancorp
EWBC
$18.6B
$2.65M 0.03%
81,007
-3,014
-4% -$107K
ALE
604
DELISTED
Allete
ALE
$2.64M 0.03%
51,036
-2,706
-5% -$151K
PZZA icon
605
Papa John's
PZZA
$812M
$2.64M 0.03%
32,050
+4,499
+16% +$413K
PKG icon
606
Packaging Corp of America
PKG
$22.9B
$2.62M 0.03%
24,044
-760
-3% -$77.7K
THC icon
607
Tenet Healthcare
THC
$21.6B
$2.62M 0.03%
106,899
-1,846
-2% -$47.2K
AGCO icon
608
AGCO
AGCO
$7.03B
$2.61M 0.03%
35,162
-1,740
-5% -$119K
SAIC icon
609
Saic
SAIC
$5.36B
$2.61M 0.03%
33,301
+3,964
+14% +$312K
PFG icon
610
Principal Financial Group
PFG
$24.5B
$2.61M 0.03%
64,729
-1,883
-3% -$80.3K
MRTX
611
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$2.6M 0.03%
15,632
-544
-3% -$74.4K
TGNA
612
DELISTED
TEGNA Inc
TGNA
$2.59M 0.03%
220,541
-4,414
-2% -$52.5K
MNTA
613
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$2.59M 0.03%
49,282
-2,576
-5% -$107K
MDU icon
614
MDU Resources
MDU
$4.35B
$2.58M 0.03%
301,927
-11,240
-4% -$96.5K
UTHR icon
615
United Therapeutics
UTHR
$21.8B
$2.57M 0.03%
25,428
-709
-3% -$77.8K
UAL icon
616
United Airlines
UAL
$40.9B
$2.56M 0.03%
73,777
+7,694
+12% +$266K
PRI icon
617
Primerica
PRI
$9.61B
$2.56M 0.03%
22,627
-1,590
-7% -$193K
SBNY
618
DELISTED
Signature Bank
SBNY
$2.55M 0.03%
30,667
-1,145
-4% -$114K
NJR icon
619
New Jersey Resources
NJR
$5.68B
$2.54M 0.03%
94,170
-5,099
-5% -$155K
HAE icon
620
Haemonetics
HAE
$4.14B
$2.53M 0.03%
29,027
-895
-3% -$78.2K
LUMN icon
621
Lumen
LUMN
$6.41B
$2.53M 0.03%
250,446
-7,887
-3% -$82K
NUVA
622
DELISTED
NuVasive, Inc.
NUVA
$2.5M 0.03%
51,506
-2,528
-5% -$136K
EV
623
DELISTED
Eaton Vance Corp.
EV
$2.49M 0.03%
65,368
-2,289
-3% -$87.5K
MRCY icon
624
Mercury Systems
MRCY
$6.71B
$2.48M 0.03%
32,063
-955
-3% -$72.4K
CPB icon
625
Campbell Soup
CPB
$6.86B
$2.48M 0.03%
51,329
+7,075
+16% +$349K

Similar funds

MetLife Investment Management's Q3 2020 Portfolio in Review

As of Q3 2020, MetLife Investment Management held 2,368 positions worth $9.13B, up 3.8% from $8.79B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

MetLife Investment Management withdrew a net $281M in Q3 2020, closing 75 positions and reducing 1,152 holdings. Its most notable exit was Slack Technologies, Inc., an estimated $7.44M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, MetLife Investment Management opened a new position in Jazz Pharmaceuticals worth $4.53M.

  • MetLife Investment Management's largest Q3 2020 buy was Jazz Pharmaceuticals: 31,753 shares worth $4.53M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $34.6M increase.
  • MetLife Investment Management's biggest Q3 2020 reduction was Apple, cutting an estimated $22.2M.
  • MetLife Investment Management fully exited Slack Technologies, Inc. in Q3 2020, selling an estimated $7.44M.
  • MetLife Investment Management's ten largest holdings make up 22% of its $9.13B portfolio in Q3 2020.
  • MetLife Investment Management opened 73 new positions and closed 75 in Q3 2020.
  • MetLife Investment Management's portfolio value rose 3.8% quarter-over-quarter to $9.13B.

Based on MetLife Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.